David Ansell to Treatment Outcome
This is a "connection" page, showing publications David Ansell has written about Treatment Outcome.
Connection Strength
0.231
-
Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany. Atherosclerosis. 2018 01; 268:99-107.
Score: 0.080
-
UK Renal Registry 11th Annual Report (December 2008): Chapter 7 Survival and causes of death of UK adult patients on renal replacement therapy in 2007: national and centre-specific analyses. Nephron Clin Pract. 2009; 111 Suppl 1:c113-39.
Score: 0.044
-
UK Renal Registry 11th Annual Report (December 2008): Chapter 5 Demographics and biochemistry profile of kidney transplant recipients in the UK in 2007: national and centre-specific analyses. Nephron Clin Pract. 2009; 111 Suppl 1:c69-96.
Score: 0.044
-
Successful but limited use of external cephalic version in Auckland. Aust N Z J Obstet Gynaecol. 2008 Oct; 48(5):467-72.
Score: 0.043
-
Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice. Atherosclerosis. 2018 04; 271:120-127.
Score: 0.020